课题基金 / 基金详情

The involvement of dihydropyrazine-induced gene damage in diabetic complication

The involvement of dihydropyrazine-induced gene damage in diabetic complication
二氢吡嗪诱导的基因损伤与糖尿病并发症的关系
批准号:
23590160
负责人:
ISHIDA TAKUMI
金额:
$3.41万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2011
资助国家:
日本
项目状态:
已结题
起止时间:
2011 至 2013

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Dihydropyrazines (DHPs), formed by nonenzymatic glycation, are known to exert various effects in vitro and in vivo. In this study, we investigated the effects of DHP on human hepatoma HepG2 cells using 2,3-dihydro-5,6-dimethylpyrazine (DHP-1), 2,3-dihydro-2,5,6-trimethylpyrazine (DHP-2), and 3-hydro-2,2,5,6-tetramethylpyrazine (DHP-3) as model compounds. All of the tested compounds exerted cytotoxic activity against HepG2 cells, and significantly so at the highest concentration. DHP-3 was the most cytotoxic drug. Additionally, DHP-3 exposure showed the significant increase of heme oxygenase-1 and glutamate cysteine ligase catalytic subunit mRNA after exposure. The serum concentration of DHPs in diabetic patient showed significant increase compared with that in non-diabetic patient. Therefore, These results suggested that the Nrf2-ARE signal pathway activated by oxidative stress is in part involved in the effect of DHP on mammalian cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
糖化反応中間体 dihydropyrazine 類による細胞障害発現機構
糖化反应中间体二氢吡嗪引起细胞损伤的机制
DOI: --
发表时间: 2012
期刊:
影响因子: --
作者: [Yanagihara N., Seki M., Nakano M., Hachisuga T., Goto Y, 情野秀晃,稲見圭子,望月正隆, 石田卓巳]
通讯作者: 石田卓巳
糖化反応中間体 dihydropyrazine 類による毒性発現機構の解析
糖化反应中间体二氢吡嗪的毒性机制分析
DOI: --
发表时间:
期刊:
影响因子: --
作者: [松岡美里, 石田卓巳, 武知進士]
通讯作者: 武知進士
海外基金